Effects of candesartan and perindopril on renal function, TGF-β1 plasma levels and excretion of prostaglandins in stable renal allograft recipients

Clinical Nephrology

Volumn 57, Issue 4, 2002, Pages 296-302

  Hetzel, G R ^a   Hermsen, D ^a   Hohlfeld, T ^a   Rettich, A ^a   Ozcan F ^a   Fussholler A ^a   Grabensee, B ^a   Plum, J ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

ACE inhibitors; Angiotensin receptor antagonists; Prostaglandins; Renal transplantation; Transforming growth factors

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PERINDOPRIL; PROSTAGLANDIN DERIVATIVE; THROMBOXANE B2; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG EFFECT; DRUG SAFETY; FEMALE; GLOMERULUS FILTRATION; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; KIDNEY ALLOGRAFT; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; PRESSURE GRADIENT; PROTEIN BLOOD LEVEL; PROTEINURIA; RECIPIENT; RISK ASSESSMENT; URINARY EXCRETION;

EID: 0036216056     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP57296     Document Type: Article

References (17)

1. Fosinopril prevents hyperfiltration and decreases proteinuria in post-transplant hypertensives
2. Interactions of transforming growth factor-β and angiotensin II in renal fibrosis
3. Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of glomerular sclerosis in aging, renal ablation and intrinsic renal disease
4. Time course of the antiproteinuric and renal haemodynamic responses to losartan in microalbuminuric IDDM
5. Long-term anti-proteinuric effect of losartan in renal transplant recipients treated for hypertension
6. 1 in transplant patients with chronic allograft nephropathy
7. Efficacy and safety of losartan in the treatment of hypertension in renal transplant recipients
8. Reduction of renal functional reserve in kidney transplant recipients: A possible role of arachidonic acid metabolism alterations
9. Dissociation between the course of the hemodynamic and antiproteinuric effects of angiotensin I-converting enzyme inhibition
10. Regression of left ventricular hypertrophy by AT1 receptor blockade in renal transplant recipients
11. TGF-β expression in renal transplant biopsies
12. Effect of nitrendipine on renal function in renal transplant patients treated with cyclosporin: A randomised trial
13. The paradox of the renin angiotensin system in chronic renal disease
14. Blood-vessel wall arachidonate metabolism and its pharmacological modification in a new in vitro assay system
15. ACE inhibitors and angiotensin II antagonists in renal transplantation: An analysis of safety and efficacy
16. The hyperfiltration in human renal transplantation
17. The effects of lisinopril on renal function in proteinuric renal transplant recipients